Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesAdministrative/Operational PolicyBlue Cross Blue Shield TX Prior Auth Codes Update …
    Ask Trek AI about this page

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    DraftBlue Cross Blue Shield - TexasPolicy N/A

    Commercial Prior Authorization Codes for Administrative Services

    Customize your policy alerts

    Sign up for all Blue Cross Blue Shield - Texas policy alerts

    Know when Blue Cross Blue Shield - Texas releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Lists CPT and HCPCS codes for which prior authorization may be required for Blue Cross Blue Shield of Texas commercial members, describes vendor routing and how providers should submit requests; coverage depends on member benefits.

    Policy Summary
    PayerBlue Cross Blue Shield - Texas
    PolicyCommercial Prior Authorization Codes for Administrative Services
    Policy CodePolicy N/A
    Change TypeNo material change (administrative list)
    Effective DateJan 1, 2025
    Next Review DateN/A
    Key ActionInitiate prior authorization via Availity Authorization & Referrals, Blue ApprovrSM, or by calling the number on the member's ID card.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    20+CPT/HCPCS codes in excerpt
    CarelonDesignated prior auth vendor
    PartialDocument part
    multipleService categories

    Coverage Criteria and Prior Authorization Requirements

    Coverage notes and management assignments

    Presence of codes indicates prior authorization may be required; actual coverage depends on the member benefit contract.

    Listing of a code on this document does not guarantee coverage; verify coverage in the member benefit booklet or by contacting customer service.
    This file is a searchable PDF; use CTRL+F to find procedure codes or service descriptions.
    Many codes on these lists are assigned to external utilization management vendors (for example, Carelon or BCBSTX); submit prior authorization requests to the designated reviewer per the mapping in this document.
    Some codes include explicit effective or update dates (examples include additions/removals effective 4/1/2026); confirm the applicable effective date for each code before submission.

    Prior authorization requirement — code list (partial)

    Listed CPT/HCPCS codes require prior authorization through Carelon.

    The following CPT codes are listed as requiring prior authorization with Carelon designated as the reviewer: 72142, 72146, 72147, 72148, 72149, 72156, 72157, 72158, 72159, 72191, 72192, 72193, 72194, 72195, 72196, 72197, 72198, 73200, 73201, 73202, 73206.

    Prior authorization list — imaging and nuclear procedures

    This section enumerates CPT codes that require prior authorization; Carelon is the named reviewer for many entries across imaging and nuclear medicine.

    Imaging and nuclear medicine CPT/HCPCS codes listed in this document (examples include 78227, 78230, 78231, 78232, 78258, 78261, 93314-93317, 93320-93325, 93350-93352, 95965, 0633T, 0649T, A9602, A9800, C8900-C8901) require prior authorization; many of these entries designate Carelon as the managing reviewer.

    Prior authorization code criteria

    List of procedure codes requiring prior authorization and assigned reviewer/vendor.

    Specified cardiology and advanced imaging procedure codes require prior authorization and in many instances are assigned to Carelon; examples include transthoracic and transesophageal echocardiography codes (93314, 93315, 93316, 93317, 93320, 93321, 93325, 93350, 93351, 93352), magnetoencephalography (95965), select advanced imaging temporary codes (0633T), and nuclear/MRI-related codes (A9602, A9800, C8900).
    Certain imaging or therapeutic procedures are mapped to BCBSTX for management (for example specific therapeutic apheresis and home infusion-related device/service codes).

    Codes requiring prior authorization

    This section enumerates codes that require prior authorization and maps them to service descriptors for coverage processing.

    Home infusion, enteral and parenteral nutrition, infusion pumps and related supplies are included on the prior authorization list; examples of HCPCS/HCPCS ranges and S-codes include B4102–B4164, B4168–B4199, B4216–B4224, B5000–B5200, B9002, B9004, B9006, B9998–B9999, E0779–E0780, K0455, Q0081–Q0085 and numerous S-codes (S5035–S5523, S9336, S9341–S9367, S9370, S9490, S9500–S9504, S9537–S9538, S9542, S9558–S9590, S9810, S9960) which require prior authorization and are mapped to reviewers such as BCBSTX per the document.

    Prior authorization requirement

    Stated codes require prior authorization; specific service descriptors and vendor mappings are provided for some codes.

    Home infusion/home therapy S-codes (for example S9341, S9342, S9365, S9366 and related per-diem descriptors) require prior authorization; drugs and nursing visits are coded separately and some home therapy codes are managed by BCBSTX.
    Selected molecular genetic CPT codes (for example 81120, 81121, 81162–81171 and many additional 81xxx series entries) are listed as requiring prior authorization and are routed to Carelon as the designated reviewer for authorization.

    Prior authorization requirements for molecular genetic testing (excerpt)

    This segment indicates which molecular genetic tests require prior authorization and the routing/vendor for authorization.

    Prior authorization is required for numerous molecular genetic laboratory procedure CPT codes; entries in the 81120–81324 series (examples: 81121, 81162–81171, 81229, 81230–81233, 81245–81248, etc.) identify Carelon as the management/reviewer for authorization.
    The document includes per-code descriptions mapping each CPT code to specific gene analyses, variant types or panel content (examples shown in the molecular code listings).

    Prior authorization list

    Listed molecular genetic CPT codes require prior authorization through Carelon. Specific test descriptions (gene, indication, method) are provided alongside each code.

    CPT codes in the 81245–81324 range and adjacent molecular CPT entries are listed as requiring prior authorization; each entry in this section pairs the CPT code with a test description or gene/variant example and designates Carelon as the reviewer for prior authorization.

    Prior authorization requirement

    Prior authorization requirement for listed molecular tests.

    Specific molecular genetic and molecular pathology CPT codes (examples include ranges 81319–81324, 81340–81364 and 81400–81402) are listed as requiring prior authorization and are mapped to Carelon for authorization processing.

    Prior authorization criteria and panel content requirements

    Prior authorization required for the listed molecular/genomic tests; certain panels must meet minimum gene content and include specified genes for the named clinical indications.

    Genomic sequence analysis panels require a minimum gene content for specific clinical indications; examples include: CPT 81410 (aortic dysfunction/dilation panel) must include sequencing of at least 9 genes (FBN1, TGFBR1, TGFBR2, COL3A1, MYH11, ACTA2, SLC2A10, SMAD3, MYLK).
    CPT 81411 (duplication/deletion analysis for aortic dysfunction) must include analyses for TGFBR1, TGFBR2, MYH11 and COL3A1.
    CPT 81412 (Ashkenazi Jewish associated disorders panel) must include sequencing of at least 9 genes (ASPA, BLM, CFTR, FANCC, GBA, HEXA, IKBKAP, MCOLN1, SMPD1).
    CPT 81413 (cardiac ion channelopathy panel) must include sequencing of at least 10 genes (including ANK2, CASQ2, CAV3, KCNE1, KCNE2, KCNH2, KCNJ2, KCNQ1, RYR2, SCN5A).
    CPT 81430–81434 and related codes specify minimum gene counts for hereditary conditions (examples: 81430 hearing loss panel must include at least 60 genes; 81432 hereditary breast cancer panel must include at least 10 genes including BRCA1/2; 81434 hereditary retinal disorders panel must include at least 15 genes).

    Coverage with prior authorization and panel requirements

    Coverage is conditioned on prior authorization and, for many tests, on meeting specified panel composition or gene-count requirements.

    Coverage for listed molecular genetic tests is conditioned on obtaining prior authorization; Carelon is identified as the reviewer for many of these codes.
    For genomic panels, the policy requires that panels meet specified minimum gene counts or include named genes for the indicated hereditary conditions (examples include hearing loss, hereditary breast cancer, hereditary retinal disorders, cardiomyopathy and inherited bone marrow failure syndromes).
    Oncology-related gene expression and sequencing assays (examples: CPT 81504 and CPT 81518–81521 series) are included on the list and require prior authorization with algorithmic outputs described in the code descriptors.

    Listed codes requiring prior authorization

    Procedure codes and brief test descriptions requiring prior authorization.

    Selected procedure and proprietary codes require prior authorization; examples include 0013M (risk score for recurrent urothelial carcinoma), 0016M/0016U (real-time PCR 51-gene expression analysis), 0022U (targeted genomic panel for NSCLC), 0045U (DCIS 12-gene recurrence score), and others; many of these entries map to Carelon for authorization review.
    Numerous U-code molecular genetic procedure entries (for example 0154U–0161U and many additional U-codes) are listed with test descriptions and Carelon designated as the reviewer for prior authorization.

    Prior authorization requirements for listed molecular/genetic tests

    Listed molecular/genetic tests require prior authorization; each entry maps a U-code to a test name/clinical indication and notes Carelon as reviewer.

    Each HCPCS U-code entry in the molecular/genetic sections requires prior authorization and is associated with a specific test description, specimen type and clinical indication; the document repeatedly maps these U-codes to Carelon as the designated prior authorization reviewer (examples include 0154U, 0155U, 0267U, 0268U, 0299U, 0306U, 0335U, 0392U, 0400U).

    Prior authorization requirements — listed tests

    Listed molecular genetic laboratory procedures require prior authorization; entries map U-codes to clinical use-cases and Carelon assignment.

    All HCPCS U-code molecular genetic procedures listed in this section require prior authorization before service is provided; many entries specify specimen types and test methods and designate Carelon as the reviewer for authorization.

    CPT, HCPCS and U-Code Listings

    Example code entriesCPT
    70473Computed tomographic (CT) cerebral perfusion analysis with contrast material(s), including image postprocessing performed without concurrent CT or CT angiography of the same anatomy. Add effective 4/1/2026
    Molecular/genetic and procedure codesmixed
    0042TCerebral Perfusion Analysis Using Computed Tomography With Contrast Administration Including Post-Processing Of Parametric Maps With Determination Of Cerebral Blood Flow, Cerebral Blood Volume, And Mean Transit Time. Remove effective 4/1/2026
    81354Cytogenomic (genome-wide) analysis for constitutional chromosomal abnormalities; interrogation of structural and copy number variants, optical genome mapping (OGM). Add effective 4/1/2026
    0508UHereditary Gynecological Cancer targeted mRNA sequence analysis panel (12 genes). Carelon. Remove effective 4/1/2026
    Lower extremity CTCPTCovered
    73700Computed Tomography Lower Extremity; Without Contrast Material
    73701Computed Tomography Lower Extremity; With Contrast Material(s)
    73702Computed Tomography Lower Extremity; Without Contrast Material Followed By Contrast Material(s) And Further Sections
    Abdomen CTCPTCovered
    74150Computed Tomography Abdomen; Without Contrast Material
    74160Computed Tomography Abdomen; With Contrast Material(s)
    74170Computed Tomography Abdomen; Without Contrast Followed By Contrast Material(s) And Further Sections
    Selected CPT codes from segmentCPTCovered
    78227Quantitative measurement(s) when performed; adrenal/salivary imaging variants listed
    78230Adrenal imaging cortex and/or medulla (mapped to salivary gland imaging in text)
    78231Adrenal imaging with serial images / salivary gland imaging
    PET/SPECT and echocardiography codesCPTCovered
    78811-78816PET imaging limited area to whole body and PET/CT with attenuation correction
    78830-78832Radiopharmaceutical localization tomographic (SPECT) with CT transmission for localization
    93303-93351Transthoracic and transesophageal echocardiography codes including stress and Doppler complements
    MEG and related temporary codesCPTCovered
    0633TMagnetoencephalography (MEG), recording and analysis; evoked magnetic fields, single modality
    0634TMagnetoencephalography (MEG), recording and analysis; evoked magnetic fields, single modality
    Cochlear implant device and accessory codesHCPCSCovered
    L8614Cochlear device including all internal and external components
    L8615Headset/headpiece for cochlear implant device replacement
    home_infusion_and_nutrition_codesHCPCS | mixedCovered
    B4102-B4164, B4168-B4199, B4216-B4224, B5000-B5200Enteral and parenteral nutrition formulas, supplies, premix solutions and additives (various unit definitions)
    B9002, B9004, B9006, B9998, B9999Enteral and parenteral infusion pumps and NOC for enteral/parenteral supplies
    E0779-E0784, E0791, E0782-E0783Ambulatory and implantable infusion pumps (miscellaneous mechanical/electric pumps)
    K0455, Q0081-Q0085Infusion pumps for uninterrupted parenteral administration and infusion therapy service codes
    S5035-S5523, S9061, S9208-S9345Home infusion therapy per diem codes including catheter care, device maintenance/repair, enteral nutrition per diem and other home therapy per diems
    Home infusion/home therapy per diem code descriptorsHCPCSCovered
    S9341Home therapy; Enteral Nutrition via gravity; administrative services, professional pharmacy services, care coordination and all necessary supplies and equipment (enteral formula and nursing visits coded separately) per diem
    S9342Home therapy; Enteral Nutrition via pump; administrative services ... per diem
    S9365Home infusion therapy TPN; one liter per day; includes standard TPN formula, supplies and equipment; per diem
    S9366Home infusion therapy TPN; more than one liter but no more than two liters per day; per diem
    Molecular genetic CPT codesCPTCovered
    81162BRCA1/BRCA2 full sequence analysis and full duplication/deletion analysis
    81163BRCA1/BRCA2 full sequence analysis
    81120IDH1 common variants
    81121IDH2 common variants
    Selected molecular genetic CPT/HCPCS codes listed in this segmentCPT | mixed
    81121Molecular genetic lab testing entry (example code listed)
    81162Molecular genetic lab testing; BRCA1/BRCA2 full sequence and duplication/deletion
    81163Molecular genetic lab testing; BRCA1/BRCA2 full sequence
    81164Molecular genetic lab testing; BRCA1/BRCA2 duplication/deletion analysis
    81212BRCA1/BRCA2 specific variant entries (examples)
    81235EGFR gene analysis common variants (NSCLC examples)
    81244FMR1 fragile X characterization (expanded size and methylation)
    81250G6PC gene analysis examples (glycogen storage disease variants)
    Molecular genetic testing CPT range entriesCPT
    81245-81324 (selected entries in this window)Molecular genetic laboratory testing codes covering specific gene analyses (full sequence, known familial variant, duplication/deletion, targeted sequence, promoter methylation, rearrangement, STR comparative analysis, microsatellite instability, etc.) as listed.
    Molecular genetic and pathology CPT groupCPTCovered
    81319-81339 rangeMolecular genetic lab testing codes for single gene analyses, sequence/full/known familial/duplication-deletion variants and other specific gene tests (examples in text).
    81340-81364 rangeMolecular genetic lab testing codes for gene rearrangement, expanded allele detection, and other sequence analyses.
    81400-81402Molecular pathology procedure levels 1-3 with examples of genes and variant types per level.
    Molecular/genomic CPT codes and descriptionsCPTCovered
    81402Molecular pathology procedure / molecular genetic lab testing examples
    81403Molecular pathology procedure level 4 (single exon by DNA sequence analysis, targeted analyses)
    81404Molecular pathology procedure level 5 (2-5 exons by sequence analysis; mutation scanning)
    81405Molecular pathology procedure level 6 (6-10 exons; regionally targeted cytogenomic array)
    81406Molecular pathology procedure level 7 (11-25 exons)
    81407Molecular pathology procedure level 8 (26-50 exons; multi-gene platforms)
    81408Molecular pathology procedure level 9 (>50 exons in single gene)
    81410Genomic sequence analysis panel for aortic dysfunction/dilation (must include at least 9 specific genes)
    81411Duplication/deletion analysis panel for aortic dysfunction (specified genes)
    81412Ashkenazi Jewish associated disorders panel (must include at least 9 genes)
    1–10 of 24
    1/3
    Selected molecular/genetic CPT codes with panel requirementsCPTCovered
    81430Genomic sequence analysis panel for hearing loss; must include sequencing of at least 60 genes
    81431Duplication/deletion analysis panel for hearing loss; must include copy number analyses for STRC and DFNB1 deletions in GJB2 and GJB6
    81432Hereditary breast cancer-related genomic panel; sequencing of at least 10 genes always including BRCA1/BRCA2, CDH1, MLH1, MSH2, MSH6, PALB2, PTEN, STK11, TP53
    81434Hereditary retinal disorders panel; sequencing of at least 15 genes
    81455Solid organ or hematolymphoid neoplasm panel with 51 or greater genes
    molecular/genetic procedure codes listedmixedCovered
    0013MAlgorithm reported as risk score for recurrent urothelial carcinoma
    0016M/0016UReal-time PCR expression analysis of 51 genes; nomogram/tumor disease index (oncology applications)
    0017M/0017UmRNA microarray/gene expression profiling and related assays (oncology profiling)
    0022UTargeted genomic sequence analysis panel for non-small cell lung neoplasia (23 genes)
    0036U/0037U/0048U/0050UExome/targeted sequencing panels interrogating somatic mutations, copy number, rearrangements, MSI, tumor mutational burden
    0045UmRNA gene expression profiling by RT-PCR of 12 genes for DCIS, reported as recurrence score
    0087U/0088UmRNA gene expression profiling for transplant biopsy tissue (allograft rejection probability scores)
    0090UmRNA gene expression profiling by RT-PCR of 23 genes for cutaneous melanoma (categorical result)
    0101U/0103U/0111U/0113U/0114U/0118UHereditary cancer panels and related NGS/Sanger/MLPA/arrayCGH with mRNA analytics
    0120UmRNA gene expression profiling of 58 genes for B-cell lymphoma classification / PMBCL vs DLBCL
    1–10 of 11
    1/2
    Molecular/genetic U-codes referencedmixedCovered
    0154UFGFR gene alteration reported from FFPE urothelial cancer tumor tissue
    0155UPALB2 mRNA sequence analysis; PIK3CA gene analysis example
    0156UCopy number/sequence analysis examples
    0158UAPC mRNA sequence analysis; MLH1
    0159UAPC mRNA sequence analysis; MSH2
    0160UAPC mRNA sequence analysis; MSH6
    0161UAPC mRNA sequence analysis; PMS2
    0162UTargeted mRNA panel for hereditary colon cancer (MLH1, MSH2, MSH6, PMS2)
    0169UNUDT15 and TPMT gene analysis (drug metabolism)
    0170UNeurology/autism RNA NGS saliva predictive algorithm
    1–10 of 53
    1/6
    select molecular/genomic U-codes in this segmentmixedCovered
    0267UOptical genome mapping / structural variant identification
    0268UGenomic sequence analysis for rare hematology disorders (e.g., AHUS) – multi-gene panels
    0297UWhole genome sequencing of paired malignant and normal DNA specimens
    0306UOncology MRD initial (baseline) targeted sequencing cell-free DNA
    0335UWhole genome sequence analysis including multiple variant types
    0392UDNA/RNA NGS 437 genes with immunotherapy response score
    0400UDNA/RNA NGS 437 genes; obstetrics expanded carrier screening 145 genes
    Representative U-code list from sectionmixedCovered
    0389UIFI27 and MCEMP1 RNA RT-qPCR risk score for KD
    0392UOncology DNA and RNA NGS 437 genes with immunotherapy response score; drug metabolism panel for psychiatry indications
    0400UObstetrics expanded carrier screening (145 genes)
    0413UOptical genome mapping for hematolymphoid neoplasm (copy number, structural rearrangements)
    0424UExosome-based urine analysis for prostate cancer risk
    0449UCarrier screening for severe inherited conditions (minimum gene set)
    0474UNGS of FFPE tumor with matched normal, 648 genes
    0493UDonor-derived cell-free DNA quantification for transplant monitoring
    0516UPharmacogenomic genotyping of 40 genes with CYP2D6 CNV analysis
    Effective date reference
    Reference effective datesListings reflect prior authorization requirements as of January 1, 2025; updates and specific code add/remove entries with an effective date of 4/1/2026 are noted in the table.
    Document update noteFile header identifies the list as the 2026 Commercial Prior Authorization Codes (updated January 2026) and states effective 1/1/2026 context for some entries.
    Coverage caveatPresence of a code on the list does not guarantee coverage — verify member benefit contract or contact customer service.
    None specified
    Specified items in excerptNone specified in the provided excerpt.
    ImplicationNo additional thresholds or numeric criteria are included in this fragment beyond those listed elsewhere in the document.
    ActionRefer to full policy or other sections for any omitted thresholds or criteria.
    Enteral formula unitization
    Enteral calorie unitization100 calories = 1 unit for many enteral formulas (enteral formula administered via feeding tube).
    Enteral volume unitization500 mL = 1 unit for certain liquid electrolyte/clear-liquid enteral products.
    Applies toEnteral formulas coded with B4xxx HCPCS entries and billed per unit according to calorie or volume definitions.
    Minimum genes required for specific panels (examples)
    Example panel minimums (aortic, Ashkenazi)Genomic sequence panels for aortic dysfunction (CPT 81410) and Ashkenazi-associated disorders (CPT 81412) must include sequencing of at least 9 genes.
    Cardiac ion channelopathy panelsGenomic sequence analysis panels for cardiac ion channelopathies (CPT 81413) must include sequencing of at least 10 genes.
    Hearing loss panel exampleHearing loss genomic panel (CPT 81430) must include sequencing of at least 60 genes.
    Minimum genes per panel (various)
    Range of minimum genes per panelDocument specifies various minimum gene counts required per panel: examples include 5, 10, 12, 15, 30, 51, 60, and 100 genes depending on the clinical panel/CPT code.
    Specific examplesCPT 81434 (hereditary retinal disorders) requires ≥15 genes; CPT 81455/81456 solid tumor panels require ≥51 genes; some mitochondrial/ genome-level tests reference ≥100 genes or full genome analysis.
    Implication for orderingPanels submitted for prior authorization must meet the stated minimum gene-count requirements for the indicated CPT code to be considered per this document.
    Gene count thresholds referenced
    Examples of gene-count thresholds referencedMultiple panels in the list specify gene counts such as 15 (retinal panels), 22 (selected hematology panels), 62 (platelet disorder panels), 437 (large oncology NGS panels), and 145 (expanded carrier screening).
    High‑complexity oncology panelsSeveral oncology assays (e.g., CPT U-codes 0392U/0400U/0401U) reference 437-gene NGS panels with immunotherapy response scoring.
    Expanded carrier screeningObstetrics expanded carrier screening example specifies 145 genes (CPT U-code 0400U).
    Gene panel sizes referenced
    Panel size spectrumGene panel sizes referenced in the document range from small targeted panels (e.g., 9–80 genes) up to very large panels (e.g., 361–648 genes) and include whole‑genome or whole‑genome+mitochondrial analyses.
    Representative large panelsExamples include 648‑gene NGS with matched normal (CPT 0474U/0475U) and other FFPE tumor panels of several hundred genes.
    Clinical impactOrdering/providers must select the CPT/U‑code that corresponds to the panel size and content; mismatch may affect prior authorization routing and coverage review.

    How Providers Initiate Prior Authorization & Actionable Notes

    Prior Authorization

    How to initiate prior authorization

    Initiate prior authorization using one of three methods: 1) Availity Authorization & Referrals; 2) Blue ApprovrSM; or 3) call the prior authorization number on the member’s ID card. For services managed by Alacura or Carelon, use the vendor contact information (Alacura: 1-866-671-4834; Carelon: 1-866-455-8415 or https://www.careloninsights.com/medical-benefitsmanagement/specialty-care).

    Prior Authorization

    Prior authorization required — sample CPT codes (Carelon)

    Prior authorization is required for the following example CPT codes; Carelon is listed as the reviewer for these entries. Submit authorization requests to Carelon for these services.

    • 72142
    • 72146
    • 72147
    • 72148
    • 72149
    • 72156
    Prior Authorization

    Prior authorization required — additional CPT codes (Carelon)

    Additional CPT codes in the pelvic/spine and related categories require prior authorization and are routed to Carelon. Providers must obtain authorization prior to service.

    • 72157
    • 72158
    • 72159
    • 72191
    • 72192
    • 72193
    • 72194
    • 72195
    • 72196
    • 72197
    • 72198
    Prior Authorization

    Upper extremity imaging prior authorization (Carelon)

    Computed tomography of the upper extremity and related imaging procedures require prior authorization and are managed by Carelon. Obtain prior authorization before scheduling.

    • 73200
    • 73201
    • 73202
    • 73206
    • 73218
    • 73219
    • 73220
    • 73221
    • 73222
    • 73223
    • 73225
    Prior Authorization

    Prior authorization — imaging and nuclear medicine codes (Carelon)

    Various imaging and nuclear medicine CPT/HCPCS procedures listed in the imaging sections require prior authorization; many of these are assigned to Carelon for review. Providers must request authorization prior to rendering these services.

    Prior Authorization

    Cardiology echocardiography codes requiring prior authorization (Carelon)

    Specific transesophageal and transthoracic echocardiography CPT codes require prior authorization and are routed to Carelon for review. Obtain authorization before performing these procedures.

    • 93314
    • 93315
    • 93316
    • 93317
    • 93320
    • 93321
    • 93325
    • 93350
    • 93351
    • 93352
    Prior Authorization

    Doppler and transthoracic/stress echocardiography prior authorization (Carelon)

    Doppler, transthoracic and stress echocardiography procedures are listed as requiring prior authorization and are assigned to Carelon. Providers must secure authorization prior to service.

    • 93320
    • 93321
    • 93325
    • 93350
    • 93351
    • 93352
    Prior Authorization

    Advanced imaging and radiology prior authorization codes (Carelon)

    Advanced imaging and radiology HCPCS/CPT entries (including certain nuclear medicine and radiopharmaceutical codes) require prior authorization; many are assigned to Carelon for review. Providers should contact Carelon for authorization routing.

    • A9602
    • A9800
    • C8900
    • C8901
    Prior Authorization

    Mixed reviewer assignments — BCBSTX for select procedures

    Some procedures (for example select imaging or therapeutic apheresis codes) are routed to BCBSTX rather than Carelon; these mixed reviewer assignments require providers to submit prior authorization to the mapped reviewer (BCBSTX) when indicated.

    • 36516
    • G0252
    • G0235
    Prior Authorization

    Prior authorization — home infusion and nutrition codes

    Home infusion, enteral and parenteral nutrition supplies, pumps, catheter care and related HCPCS/CPT and S-/B- codes require prior authorization. Prior authorization must be obtained before initiating home infusion or home nutrition services.

    Prior Authorization

    Prior authorization required — home infusion/home therapy S‑codes

    Per‑diem and hourly home infusion/home therapy S‑codes require prior authorization; descriptors include enteral nutrition (gravity/pump/bolus), TPN tiers, hydration tiers, and various infusion therapies. Obtain authorization per the mapped reviewer before billing.

    • S9336
    • S9338
    • S9339
    • S9341
    • S9342
    • S9343
    • S9345
    • S9346
    • S9347
    • S9349
    • S9351
    • S9353
    • S9355
    • S9357
    • S9359
    • S9361
    • S9363
    • S9365
    • S9366
    • S9367
    • S9370
    • S9372
    Prior Authorization

    Prior authorization required — select medical transport codes (Alacura)

    Certain nonemergent medical transport codes (including fixed-wing air transport and ambulance service codes) require prior authorization and are mapped to vendor Alacura; contact Alacura for authorization routing.

    • A0430
    • A0435
    • S9960
    Prior Authorization

    Prior authorization required — listed molecular genetic CPT codes (Carelon)

    Selected molecular genetic CPT codes (examples: 81120, 81121, 81162–81171) require prior authorization and are routed to Carelon for review. Providers must obtain prior authorization for these molecular genetic laboratory tests before testing.

    • 81120
    • 81121
    • 81162
    • 81163
    • 81164
    • 81165
    • 81166
    • 81167
    • 81168
    • 81170
    • 81171
    Prior Authorization

    Prior authorization routing for molecular genetic tests (Carelon)

    Numerous molecular genetic laboratory procedure CPT codes are routed to Carelon for prior authorization; providers must submit authorization requests to Carelon per the listed mapping before performing testing.

    Prior Authorization

    Prior authorization required — molecular genetic CPT codes (81245–81324)

    A broad range of CPT molecular genetic test codes (81245–81324 range and related entries) require prior authorization through Carelon; obtain authorization before ordering/testing.

    • 81245
    • 81246
    • 81247
    • 81248
    • 81249
    • 81250
    • 81251
    • 81252
    • 81253
    • 81254
    • 81255
    • 81256
    • 81257
    • 81258
    • 81259
    • 81260
    • 81261
    • 81262
    • 81263
    • 81264
    • 81265
    • 81266
    • 81269
    Prior Authorization

    Prior authorization required — additional molecular CPT codes (Carelon)

    Additional molecular genetic and molecular pathology CPT codes are listed as requiring prior authorization through Carelon; providers must obtain authorization prior to testing.

    • 81319
    • 81320
    • 81321
    • 81322
    • 81323
    • 81324
    • 81326
    • 81327
    • 81328
    • 81330
    • 81331
    • 81332
    • 81333
    • 81334
    • 81335
    • 81337
    • 81338
    • 81339
    • 81340
    • 81341
    • 81342
    • 81343
    • 81344
    Prior Authorization

    Prior authorization required — molecular genetic CPT codes with panel requirements (Carelon)

    A range of molecular genetic/genomic CPT codes (81402–81434 and related) require prior authorization and include panel‑specific requirements; Carelon is identified as the reviewer for many entries. Obtain prior authorization and ensure panels meet any minimum gene or content requirements noted.

    • 81402
    • 81403
    • 81404
    • 81405
    • 81406
    • 81407
    • 81408
    • 81410
    • 81411
    • 81412
    • 81413
    • 81414
    • 81415
    • 81417
    • 81418
    • 81419
    • 81422
    • 81425
    • 81426
    • 81427
    • 81430
    • 81431
    Documentation Required

    Prior authorization — panel gene‑count and content requirements

    Certain genomic sequence analysis panels have minimum gene‑count or named‑gene requirements (examples): hearing loss panels must include sequencing of at least 60 genes; hereditary breast‑cancer panels must include at least 10 genes including BRCA1/BRCA2; aortic panels must include at least 9 specified genes. Prior authorization and panel content verification are required.

    • 81410 (aortic panel) — must include at least 9 specified genes
    • 81430 (hearing loss) — must include sequencing of at least 60 genes
    • 81431 (hearing loss duplication/deletion) — must include STRC and DFNB1 copy number analyses
    • 81432 (hereditary breast cancer) — must include sequencing of at least 10 genes including BRCA1/BRCA2
    • 81434 (hereditary retinal disorders) — must include sequencing of at least 15 genes
    Prior Authorization

    Prior authorization required — molecular/genetic U‑codes (Carelon)

    Many molecular genetic and genomic U‑codes require prior authorization and are mapped to Carelon as the reviewer; providers must obtain prior authorization for these U‑coded laboratory services before performance.

    • 0267U
    • 0268U
    • 0269U
    • 0270U
    • 0271U
    • 0272U
    • 0273U
    • 0274U
    • 0276U
    • 0306U
    • 0307U
    • 0313U
    • 0389U
    • 0392U
    • 0400U
    Prior Authorization

    Prior authorization mapping and vendor — molecular/genetic U‑codes (Carelon)

    The policy maps numerous molecular genetic/genomic procedure U‑codes to Carelon for prior authorization and medical review; submit prior authorization requests to Carelon per the code-specific mapping before ordering testing.

    Note
    Note

    Definitions and Notes

    TDI indicated on member ID
    PurposeIdentifier used to route prior authorization requests as noted in the document header.
    VerificationCheck the member ID card for TDI designation when initiating authorization for fully insured members.
    Searchable PDF — use CTRL+F
    Searchable PDF guidanceThis file is a searchable PDF; use CTRL+F to search procedure codes or descriptions.
    Use caseQuickly locate CPT/HCPCS/U‑codes or descriptive text within the document for authorization and billing preparations.
    NoteThe list is not exhaustive and presence of a code does not guarantee coverage; confirm benefits separately.
    Carelon — designated prior authorization vendor
    Designated prior authorization vendorCarelon is the designated prior authorization vendor/plan reviewer for many procedures and molecular genetic tests listed in this document.
    Examples of assignmentsNumerous CPT and U‑codes in the molecular genetic sections and advanced imaging entries show mapping to Carelon for authorization routing.
    Action for providersSubmit prior authorization requests for the mapped codes to Carelon per the routing instructions in the full document.
    Advanced Imaging / Cardiology — clinical category
    Clinical categories exampleAdvanced Imaging/Radiology and Cardiology are clinical categories under which many listed CPT codes (imaging, PET/SPECT, echocardiography) are organized.
    Examples of modalities/codesEntries include PET/SPECT, myocardial perfusion imaging, and MRI/MRA codes that are routed for prior authorization review.
    Reviewer mappingMany of these imaging entries indicate Carelon as the reviewer for prior authorization processing.
    Utilization management vendor / reviewer — Carelon
    Utilization management vendor notedCarelon is repeatedly referenced as the utilization management vendor / plan reviewer for many prior authorization entries in this document.
    Multiple service areasCarelon mapping appears across advanced imaging, molecular genetic lab testing, and U‑code sections.
    Provider actionFollow the Carelon submission process when codes are mapped to Carelon in the listing.
    PET / SPECT — imaging modalities
    Imaging modalities referencedPET and SPECT imaging modalities are referenced in code descriptions (e.g., PET metabolic evaluation, SPECT with CT localization).
    Associated codesExamples include PET/SPECT CPT ranges and radiopharmaceutical localization codes assigned for prior authorization review.
    RoutingMany nuclear medicine imaging entries map to Carelon for prior authorization.
    Effective date note — 1/1/2026 adds
    Future effective date notesSeveral entries include 'Add effective 1/1/2026' indicating future effective dates for authorization requirements on those codes.
    Document contextHeader and select code lines note updates and effective dates; providers should verify the applicable effective date for a given code.
    ActionWhen a code shows a future effective date, confirm whether the authorization requirement applies on the date of service planned.
    Reviewer assignment
    Reviewer assignment labelEntries include an entity label (e.g., Carelon, BCBSTX, Alacura) indicating which reviewer/vendor handles prior authorization for that code.
    ExamplesExamples: Carelon = Carelon for many molecular tests; BCBSTX or Alacura appear for select home infusion or transport codes.
    Provider instructionUse the reviewer mapping in the listing to determine where to submit the prior authorization request.
    Per diem — home infusion
    Per diem definition (home infusion)Per diem codes represent a daily rate covering administrative services, professional pharmacy services, care coordination, supplies and equipment; drugs and nursing visits are coded separately.
    TPN per diem tiersTPN per diem S‑codes are tiered by daily volume (one liter, >1–2L, >2–3L, >3L) and include standard formulas and supplies in the per diem.
    Billing noteDo not combine per diem S‑codes with overlapping hourly/home infusion codes when indicated in descriptors.
    Unit — enteral/parenteral nutrition
    Unit definitions for nutritionUnit measures used for enteral/parenteral nutrition: 100 calories = 1 unit for enteral formulas; 500 mL = 1 unit for certain liquid electrolyte/clear-liquid products.
    Applies to HCPCS B4xxx codesThese unit definitions are applied to enteral formula HCPCS codes (B4149, B4150, B4155, B4158, etc.) in the listing.
    Provider billing implicationBill the appropriate number of units based on the product's calories or volume as defined in the listing.
    TPN volume tiers
    TPN volume tiers describedTotal parenteral nutrition per diem codes (S9365–S9373, etc.) are tiered by daily volume: one liter, >1–2L, >2–3L, >3L per day with supplies and standard formulas included in the per diem.
    Coding guidanceDrugs and nursing visits are coded separately from the TPN per diem descriptors.
    Reviewer mappingMany TPN per diem entries are mapped to BCBSTX for prior authorization in this document segment.
    Per diem vs hourly S-codes
    Per diem vs hourly S‑codesSome home infusion S‑codes are billed per diem (daily rate including administrative and supplies) while others (e.g., S9810 referenced elsewhere) are billed hourly; the listing instructs not to combine incompatible codes.
    ExampleS9503/S9504 family are per diem antibiotic/antiviral infusion descriptors; certain nursing/time codes are hourly and billed separately.
    Billing cautionFollow descriptor guidance to avoid incorrect use of per diem codes with hourly codes.
    Carelon — molecular genetic reviewer
    Carelon mapped for molecular testsCarelon is the designated prior authorization reviewer referenced for many molecular genetic CPT codes and numerous HCPCS U‑codes in the molecular/genetic sections.
    ScopeMapping covers single‑gene tests, multi‑gene panels, genomic/exome/genome analyses, and many U‑codes for specialized laboratory assays.
    Provider instructionSubmit prior authorization requests for mapped molecular genetic tests to Carelon per the routing indicated in the listing.
    Service descriptor — Molecular Genetic Lab Testing
    Service descriptor usedThe listing repeatedly uses the service descriptor 'Molecular Genetic Lab Testing' to denote laboratory genetic/molecular procedures for which prior authorization is required.
    Applies to CPT and U‑codesThis descriptor appears across many CPT codes (81120–81324, 81400–81408, etc.) and U‑codes in the molecular sections.
    ActionTreat entries labeled 'Molecular Genetic Lab Testing' as subject to the molecular test prior authorization requirements and reviewer routing.
    STR comparative analysis
    STR comparative analysisComparative analysis using short tandem repeat (STR) markers is referenced in entries (e.g., prenatal/fetal specimen identity testing and aneuploidy workflows).
    Typical useUsed for zygosity testing, donor/recipient identity verification, and fetal sample comparisons as described in the U‑code entries.
    Specimen typesMay be performed on samples such as blood, buccal swab, cord blood, or fetal specimens depending on the entry.
    Microsatellite instability analysis
    Microsatellite instability analysisMicrosatellite instability (MSI) analysis of markers for mismatch repair deficiency is included (e.g., CPT 81301 and multiple tumor panels that report MSI).
    Clinical contextsMSI testing appears in hereditary colorectal cancer/Lynch syndrome contexts and in tumor profiling panels for oncology indications.
    ActionOrder the CPT/U‑code that corresponds to MSI testing and ensure prior authorization per the listed reviewer mapping.
    Level 1 — Molecular Pathology Procedure
    Molecular Pathology Level 1Level 1 molecular pathology procedure definition is used to classify lower analytic complexity molecular tests (document references molecular pathology procedure levels across 81400–81408).
    Associated CPT rangeMolecular pathology procedure levels correspond to CPT groupings (81400 series) that define analytic scope and complexity.
    ImplicationSelect the CPT level consistent with the analytic complexity of the test when requesting prior authorization.
    Level 2 — Molecular Pathology Procedure
    Level 2 definitionMolecular Pathology Procedure Level 2 in the document denotes tests such as 2–10 SNPs, single methylated or somatic variant detection or dynamic mutation detection (e.g., CPT 81401 series).
    Coding noteThese level definitions map to CPT analytic complexity and inform code selection for prior authorization.
    Reviewer mappingLevel 2 procedure codes are listed with Carelon as the reviewer in many entries.
    Level 3 — Molecular Pathology Procedure
    Level 3 definitionMolecular Pathology Procedure Level 3 refers to higher analytic complexity (>10 SNPs, multiple methylated or somatic variants, immunoglobulin/T‑cell receptor gene rearrangements, copy number changes, LOH, UPD), mapped to CPT 81402 and related codes.
    ImplicationHigher complexity tests require appropriate CPT selection and prior authorization per the listing.
    Provider actionVerify that the test's analytic scope aligns with the level chosen when submitting an authorization request.
    Genomic sequence analysis panel — definition and requirements
    Genomic sequence analysis panel definitionGenomic sequence analysis panels (CPT 81410, 81430, 81432, etc.) are multi‑gene sequencing tests and many entries require panels to include a minimum set or number of genes for the indicated clinical condition.
    Examples of required genesSome CPT entries list specific genes that must be included (e.g., FBN1, TGFBR1/TGFBR2 for aortic panels; BRCA1/2 and other named genes for hereditary breast cancer panels).
    ActionEnsure the panel's gene content meets the minimum and includes any named genes before submitting for prior authorization.
    Whole Mitochondrial Genome
    Whole Mitochondrial GenomeWhole mitochondrial genome sequencing requires sequence analysis of the entire mitochondrial genome with heteroplasmy detection (e.g., CPT 81460).
    Clinical examplesUsed for disorders such as MELAS, MERRF, Leber hereditary optic neuropathy and other mitochondrial syndromes.
    Prior authorizationThese tests are included in the molecular section and are routed for prior authorization as listed (Carelon mapping present).
    mRNA gene expression profiling
    mRNA gene expression profilingmRNA gene expression profiling (e.g., RT‑PCR or microarray) is referenced for diagnostic/prognostic algorithms (multiple U‑code examples such as 0045U, 0087U, 0120U) and reported as scores or categorical results.
    Clinical examplesUses include DCIS recurrence score (0045U), transplant biopsy rejection probability (0087U/0088U), and B‑cell lymphoma classification (0120U).
    Prior authorizationSuch assays are listed as requiring prior authorization with Carelon mapping for many entries.
    Targeted genomic sequence analysis
    Targeted genomic sequence analysisTargeted genomic sequence analysis panels interrogate a defined set of genes for sequence variants and are represented by multiple U‑codes/CPT entries in the listing (e.g., 0022U, 0037U, 0487U).
    Examples0022U = targeted panel for NSCLC (23 genes); 0037U/0036U and others represent tumor panels of varying gene counts and analytic scopes.
    Provider actionConfirm the targeted panel's gene content aligns with the CPT/U‑code and meets prior authorization requirements before ordering.
    Carelon — prior authorization reviewer for U-codes
    Carelon as designated reviewer for U‑codesCarelon is listed alongside many HCPCS U‑codes and is the designated prior authorization reviewer for numerous molecular/genetic U‑codes in the document.
    Scope of U‑codesU‑codes cover whole‑genome/transcriptome assays, large NGS panels, optical genome mapping, MRD assays, and specialized expression/algorithmic tests.
    Provider instructionFor U‑codes mapped to Carelon, submit prior authorization requests to Carelon per the document's routing guidance.
    Carelon — named prior authorization entity for many U-codes
    Carelon referenced as named vendor/processorCarelon is repeatedly named as the vendor/processor assigned to many U‑codes for authorization handling in the molecular/genetic sections.
    Examples of assigned U‑codesEntries such as 0272U, 0274U, 0287U, 0299U, 0306U, etc., show Carelon mapping for authorization review.
    ActionProviders should follow the Carelon submission pathway for these U‑codes to obtain prior authorization.
    Specimen types
    Specimen types listedSpecimen types referenced across entries include blood, plasma, saliva, buccal swab, amniotic fluid, FFPE tissue, fresh/frozen tissue, urine and bone marrow.
    Contextual useDifferent molecular tests specify acceptable specimen types (e.g., FFPE for tumor panels, plasma for cfDNA assays, amniotic fluid for fetal testing).
    Provider implicationEnsure the correct specimen type is collected and documented to match the CPT/U‑code and authorization request.
    Specimen and methodology examples
    Specimen and methodology examplesExamples include FFPE tissue, plasma, whole blood, urine, saliva, buccal swab, and methods such as NGS, RT‑qPCR, ddPCR, methylation‑specific PCR, and optical genome mapping.
    Assay examplesOptical genome mapping, whole genome sequencing, DNA/RNA NGS, and methylation assays are specifically referenced across U‑code entries.
    Ordering noteOrder the assay using the CPT/U‑code that matches the methodology and specimen to ensure appropriate prior authorization routing.

    Policy Revision History

    2025-01-01effective_date

    Listings reflect prior authorization requirements as of January 1, 2025; presence on the list does not guarantee coverage — verify member benefits.

    2026-01-01updateLatest

    Document updated January 2026 noting file title '2026 Commercial Prior Authorization Codes for Administrative Services Only' and an effective date of 1/1/2026 for updated content.

    Policy Summary
    PayerBlue Cross Blue Shield - Texas
    PolicyCommercial Prior Authorization Codes for Administrative Services
    Policy CodePolicy N/A
    Change TypeNo material change (administrative list)
    Effective DateJan 1, 2025
    Next Review DateN/A
    Key ActionInitiate prior authorization via Availity Authorization & Referrals, Blue ApprovrSM, or by calling the number on the member's ID card.
    SourceLink
    On This Page
    Coverage Criteria and Prior Authorization RequirementsCPT, HCPCS and U-Code ListingsHow Providers Initiate Prior Authorization & Actionable NotesDefinitions and NotesPolicy Revision History
  1. S9373
  2. S9374
  3. S9375
  4. S9376
  5. S9379
  6. S9490
  7. S9494
  8. S9497
  9. S9500
  10. S9501
  11. S9503
  12. S9504
  13. S9529
  14. S9537
  15. S9538
  16. S9542
  17. S9558
  18. S9559
  19. S9560
  20. S9590
  21. S9810
  22. S9960
  23. 81271
  24. 81272
  25. 81273
  26. 81274
  27. 81275
  28. 81276
  29. 81277
  30. 81278
  31. 81279
  32. 81283
  33. 81284
  34. 81286
  35. 81287
  36. 81288
  37. 81289
  38. 81290
  39. 81291
  40. 81292
  41. 81293
  42. 81294
  43. 81295
  44. 81296
  45. 81297
  46. 81298
  47. 81299
  48. 81300
  49. 81301
  50. 81302
  51. 81303
  52. 81304
  53. 81305
  54. 81306
  55. 81308
  56. 81309
  57. 81310
  58. 81311
  59. 81312
  60. 81313
  61. 81314
  62. 81315
  63. 81317
  64. 81318
  65. 81319
  66. 81320
  67. 81321
  68. 81322
  69. 81323
  70. 81324
  71. 81345
  72. 81347
  73. 81348
  74. 81349
  75. 81350
  76. 81351
  77. 81352
  78. 81353
  79. 81355
  80. 81357
  81. 81360
  82. 81361
  83. 81362
  84. 81363
  85. 81364
  86. 81400
  87. 81401
  88. 81402
  89. 81432
  90. 81434